Arensia Exploratory Medicine Gmb H
Research, Düsseldorf, Massachusetts, 02459, United States, 201-500 Employees
Who is ARENSIA EXPLORATORY MEDICINE GMBH
ARENSIA is a German operator of professional research clinics, dedicated to performing early phase clinical trials - Phase IB, IIA, and PROOF OF CONCEPT - with novel compounds. Our trials...
Read More
-
Headquarters: Düsseldorf, Massachusetts, 02459, United States
-
Date Founded: 2010
-
Employees: 201-500
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
-
CEO:
Ekaterine Kanchaveli
Email
Phone
SIC Code: 
Does something look wrong? Fix it. | View contact records from ARENSIA EXPLORATORY MEDICINE GMBH
ARENSIA Exploratory Medicine GmbH Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding ARENSIA Exploratory Medicine GmbH
Answer: ARENSIA Exploratory Medicine GmbH's headquarters are located at Düsseldorf, Massachusetts, 02459, United States
Answer: ARENSIA Exploratory Medicine GmbH's official website is https://arensia-em.com
Answer: ARENSIA Exploratory Medicine GmbH's revenue is $5 Million to $10 Million
Answer: ARENSIA Exploratory Medicine GmbH's SIC: 8731
Answer: ARENSIA Exploratory Medicine GmbH's NAICS: 541715
Answer: ARENSIA Exploratory Medicine GmbH has 201-500 employees
Answer: ARENSIA Exploratory Medicine GmbH is in Research
Answer: ARENSIA Exploratory Medicine GmbH contact info: Phone number: Website: https://arensia-em.com
Answer: ARENSIA is a German operator of professional research clinics, dedicated to performing early phase clinical trials - Phase IB, IIA, and PROOF OF CONCEPT - with novel compounds. Our trials involve a wide range of patient populations. ARENSIA clinics are designed to enable patient's access to innovative therapies early in the drug development process. Patient's safety and comfort are of paramount importance at ARENSIA. Our facilities are strategically located within or adjacent to large university/private hospitals in the following cities: Phoenix, Arizona USA, Bucharest and Cluj-Napoca in Romania, Chisinau in Moldova, Tbilisi in Georgia, Kyiv in Ukraine and Sofia in Bulgaria. Due to its dedicated research-oriented infrastructure, ARENSIA achieves a time reduction of avg. 60% through unrivalled recruiting performance vs. typical clinical trial sites which are overcrowded by daily hospital duties, lack of staff, competition for the same populations, and long timelines for contract negotiations. The shortened time and the different setup of concentrating effort on a few ARENSIA Clinics (instead of the traditional high number of sites) lead to an overall budget reduction of 50% for a typical Phase IB/IIA PROOF OF CONCEPT trial. 93% repeat business proves that ARENSIAs value proposition is the long-expected disruptive breakthrough in time and cost! This has allowed our continuous growth while collaborating with the leading pharmaceutical companies worldwide, numerous biotechs, as well as global CROs.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
CEO at ARENSIA Exploratory Medicine GmbH
Sign in to CIENCE GO Data to uncover contact details
Free credits every month